ditercalinium has been researched along with Di Guglielmo Disease in 2 studies
ditercalinium: structure given in first source; RN given refers to parent cpd
Excerpt | Relevance | Reference |
---|---|---|
"Ditercalinium (NSC 335153) is a novel 7H-pyridocarbazole dimer in which the two monomers are joined by a rigid bis(ethylpiperidinyl)-linking chain producing a molecule capable of bisintercalation into DNA with extremely high affinity." | 1.27 | Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells. ( Bueti, C; Darzynkiewicz, Z; Melamed, MR; Traganos, F, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Traganos, F | 2 |
Bueti, C | 2 |
Kapuscinski, J | 1 |
Darzynkiewicz, Z | 2 |
Melamed, MR | 1 |
2 other studies available for ditercalinium and Di Guglielmo Disease
Article | Year |
---|---|
The antitumor intercalating drug ditercalinium binds preferentially to RNA in Friend erythroleukemia cells.
Topics: Acridine Orange; Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Carbazoles; Ce | 1989 |
Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Cycle; DNA, Neoplasm; Intercalating Agents; Leukemi | 1987 |